Clinical Characteristics,Diagnosis and Treatment of 17α-hydroxylase Deficiency:Analysis of Two Adults
Department of Endocrinology,the General Hospital of Western Theater Command,Chengdu 610083,China
*Corresponding author:YOU Zhiqing,Associate chief physician;E-mail:94099156@qq.com
LIU Junjing,REN Li,ZHANG Wei, et al. Clinical Characteristics,Diagnosis and Treatment of 17α-hydroxylase Deficiency:Analysis of Two Adults [J]. Chinese General Practice, 2021, 24(9): 1140-1143. DOI: 10.12114/j.issn.1007-9572.2020.00.571.
刘君静,任丽,张卫等. 成年17α羟化酶缺陷症二例临床特征及诊疗分析[J]. 中国全科医学, 2021, 24(9): 1140-1143. DOI: 10.12114/j.issn.1007-9572.2020.00.571.
[1]OH Y K,RYOO U,KIM D,et al.17α-hydroxlyase/17,20-lyase deficiency in three siblings with primary amenorrhea and absence of secondary sexual development[J].J Pediatr Adolesc Gynecol,2012,25(5):e103-105.DOI:10.1016/j.jpag.2012.05.008.
[2]KRONE N,ARLT W.Genetics of congenital adrenal hyperplasia[J].Best Pract Res Clin Endocrinol Metab,2009,23(2):181-192.DOI:10.1016/j.beem.2008.10.014.
[3]SUN M,YAN X,FENG A,et al.A novel compound heterozygous mutation in the CYP17A1 gene in a patient with 17α-hydroxylase/17,20-lyase deficiency[J].Discov Med,2017,24(133):175-182.
[4]WINTER J S,COUCH R M,MULLER J,et al.Combined 17-hydroxylase and 17,20-desmolase deficiencies:evidence for synthesis of a defective cytochrome P450c17[J].J Clin Endocrinol Metab,1989,68(2):309-316.DOI:10.1210/jcem-68-2-309.
[5]BIASON-LAUBER A,BOSCARO M,MANTERO F,et al.Defects of steroidogenesis[J].J Endocrinol Invest,2010,33(10):756-766.DOI:10.1007/BF03346683.
[6]MULA-ABED W A S,PAMBINEZHUTH F B,AL-KINDI M K,et al.Congenital adrenal hyperplasia due to 17-alpha-hydoxylase/17,20-lyase deficiency presenting with hypertension and pseudohermaphroditism:first case report from Oman[J].Oman Med J,2014,29(1):55-59.DOI:10.5001/omj.2014.12.
[7]MIKAMI Y,TAKAI Y,OBATA-YASUOKA M,et al.Diagnosis of female 17α-hydroxylase deficiency after gonadectomy:a case report[J].J Med Case Rep,2019,13(1):235.DOI:10.1186/s13256-019-2166-9.
[8]TAKEDA Y,YONEDA T,DEMURA M,et al.Genetic analysis of the cytochrome P-450c17alpha(CYP17)and aldosterone synthase(CYP11B2)in Japanese patients with 17alpha-hydroxylase deficiency[J].Clin Endocrinol(Oxf),2001,54(6):751-758.DOI:10.1046/j.1365-2265.2001.01272.x.
[9]CHORMANSKI D,MUZIO M R.C 17 Hydroxylase Deficiency[M/OL].Treasure Island(FL):StatPearls Publishing,2020[2020-06-15].http://www.ncbi.nlm.nih.gov/books/NBK546644/.
[10]FONTENELE R,COSTA-SANTOS M,KATER C E.17α-hydroxylase deficiency is an underdiagnosed disease:high frequency of misdiagnoses in a large cohort of brazilian patients[J].Endocr Pract,2018,24(2):170-178.DOI:10.4158/EP171987.OR.
[11]WANG M,WANG H,ZHAO H,et al.Prevalence of CYP17A1 gene mutations in 17α-hydroxylase deficiency in the Chinese Han population[J].Clin Hypertens,2019,25:23.DOI:10.1186/s40885-019-0128-6.
[12]蒋建发,邓燕,薛薇,等.46,XY17α-羟化酶缺乏30例手术治疗分析[J].中国医学科学院学报,2016,38(5):559-562.DOI:10.3881/j.issn.1000-503X.2016.05.012.
JIANG J F,DENG Y,XUE W,et al.Surgical therapy of 17α-hydroxylase deficiency in 30 patients[J].Acta Academiae Medicinae Sinicae,2016,38(5):559-562.DOI:10.3881/j.issn.1000-503X.2016.05.012.
[13]SCHWAB K O,MOISAN A M,HOMOKI J,et al.17alpha-hydroxylase/17,20-lyase deficiency due to novel compound heterozygote mutations:treatment for tall stature in a female with male pseudohermaphroditism and spontaneous puberty in her affected sister[J].J Pediatr Endocrinol Metab,2005,18(4):403-411.DOI:10.1515/jpem.2005.18.4.403.
[14]TURAN S,BEREKET A,GURAN T,et al.Puberty in a case with novel 17-hydroxylase mutation and the putative role of estrogen in development of pubic hair[J].Eur J Endocrinol,2009,160(2):325-330.DOI:10.1530/EJE-08-0632.
[15]MATSUZAKI S,YANASE T,MURAKAMI T,et al.Induction of endometrial cycles and ovulation in a woman with combined 17alpha-hydroxylase/17,20-lyase deficiency due to compound heterozygous mutations on the p45017alpha gene[J].Fertil Steril,2000,73(6):1183-1186.DOI:10.1016/s0015-0282(00)00500-8.
[16]LEES B,STEVENSON J C.The prevention of osteoporosis using sequential low-dose hormone replacement therapy with estradiol-17 beta and dydrogesterone[J].Osteoporos Int,2001,12(4):251-258.DOI:10.1007/s001980170113.